½ÃÀ庸°í¼­
»óǰÄÚµå
1767728

ÇÁ·ÎÅ×À̳ª¾ÆÁ¦ K ½ÃÀå : Çüź°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Proteinase K Market, By Form, By Application, By End User, By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÇÁ·ÎÅ×À̳ª¾ÆÁ¦ K ½ÃÀåÀº 2025³â¿¡´Â 3,150¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 4,800¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 6.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸®Æ÷Æ® ¹üÀ§ ¸®Æ÷Æ® »ó¼¼
±âÁØ¿¬µµ 2024 2025³â ½ÃÀå ±Ô¸ð 3,150¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR : 6.20% 2032³â °¡Ä¡ ¿¹Ãø 4,800¸¸ ´Þ·¯

ÇÁ·ÎÅ×À̳ª¾ÆÁ¦ K(ÇÁ·ÎÅ×¾ÆÁ¦ K ¶Ç´Â ¿£µµÆéƼ´Ù¾ÆÁ¦ K¶ó°íµµ ÇÔ)´Â ºÐÀÚ»ý¹°Çп¡¼­ ³Î¸® »ç¿ëµÇ´Â ±¤¹üÀ§ÇÑ ½ºÆåÆ®·³ÀÇ ¼¼¸° ÇÁ·ÎÅ×¾ÆÁ¦ÀÔ´Ï´Ù. ÇÁ·ÎÅ×¾ÆÁ¦ K´Â ¸ð¹ß Äɶóƾ(¸ð¹ß)À» ¼ÒÈ­ÇÒ ¼ö ÀÖÀ¸¹Ç·Î 'ÇÁ·ÎÅ×¾ÆÁ¦ K'¶ó°í ºÒ¸³´Ï´Ù. ±¤¹üÀ§ÇÑ Æ¯À̼ºÀ» °¡Áö°í ÀÖÀ¸¹Ç·Î ÇÙ»ê º¹ÇÕü ¼¼Ã´ ¹× ¼¼Æ÷ ¿ëÇØ¿¡ À¯¿ëÇϸç, ÀϹÝÀûÀ¸·Î mRNA ¹× °íºÐÀÚ·® DNAÀÇ ºÐ¸®, ±âŸ È¿¼Ò Ȱµ¿ÀÇ ºÒȰ¼ºÈ­¿¡ »ç¿ëµË´Ï´Ù. ÀÌ È¿¼Ò´Â 1974³â °õÆÎÀÌ Engyodontium album(±¸ Tritirachium album)ÀÇ ÃßÃâ¹°¿¡¼­ ¹ß°ßµÇ¾ú½À´Ï´Ù. ÇÁ·ÎÅ×À̳ªÁ¦ K´Â ºÐÀÚ »ý¹°Çп¡¼­ ´Ü¹éÁúÀ» ¼ÒÈ­Çϰí ÇÙ»ê Á¦Á¦¿¡¼­ ¿À¿°À» Á¦°ÅÇϱâ À§ÇØ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ÇÁ·ÎÅ×À̳ªÁ¦ K¸¦ ÇÙ»ê Á¦Á¦¿¡ ÷°¡Çϸé Á¤Á¦ °úÁ¤¿¡¼­ DNA¿Í RNA¸¦ ºÐÇØÇÒ ¼ö ÀÖ´Â ´ºÅ¬·¹¾ÆÁ¦¸¦ ºü¸£°Ô ºñȰ¼ºÈ­½ÃÄÑ ÀÌ·¯ÇÑ ¿ëµµ¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ÇÁ·ÎÅ׫¤«Ê?«¼ K´Â ¾çÀÌ¿ÂÀÔ´Ï´Ù. µµµ¥½Ç Ȳ»ê³ªÆ®·ýÀ̳ª ¿ì·¹¾Æ¿Í °°Àº ´Ü¹éÁúÀ» º¯¼º½ÃŰ´Â È­Çй°Áú, EDTA¿Í °°Àº ų·¹ÀÌÆ®Á¦, ¼³ÇÁÈ÷µå¸± ½Ã¾à, Æ®¸³½ÅÀ̳ª Ű¸ðÆ®¸³½Å ¾ïÁ¦Á¦ÀÇ Á¸Àç ÇÏ¿¡¼­µµ Ȱ¼ºÀ» ³ªÅ¸³»¹Ç·Î ÀÌ·¯ÇÑ ¿ëµµ¿¡ ¸Å¿ì ÀûÇÕÇÕ´Ï´Ù. ÇÁ·ÎÅ×À̳ªÁ¦ K´Â ¼¼Æ÷ ¿ëÇØ¾×(Á¶Á÷, ¼¼Æ÷¹è¾ç ¼¼Æ÷)¿¡¼­ ´Ü¹éÁúÀÇ ÆÄ±«¿Í ÇÙ»ê ¹æÃâ¿¡ »ç¿ëµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÃÀå °³¹ßÀ» °¡¼ÓÈ­Çϰí È®ÀåÇÏ°í Æ÷Æ®Æú¸®¿À¸¦ ´õ¿í ´Ù¾çÈ­Çϱâ À§ÇØ ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀº ÇÁ·ÎÅ׾Ƴ×ÀÌÁî K È¿¼Ò¸¦ »õ·Î¿î Áø´Ü ŰƮ¿¡ Àû¿ëÇÏ´Â µî ¼ºÀå Àü·«À» äÅÃÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è ÇÁ·ÎÅ׾Ƴ×ÀÌÁî K ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2020³â 12¿ù 25ÀÏÀÚ Journal Med¿¡ °ÔÀçµÈ ³í¹®¿¡ µû¸£¸é ÇÁ·ÎÅ×À̳ªÁ¦ K´Â ¾à°£ÀÇ ¹Î°¨µµ °¨¼Ò¸¸À¸·Î ÇÙ»ê ÃßÃâÀÇ Àú·ÅÇÏ°í ºü¸£°í ½¬¿î ´ë¾ÈÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ±×·¡¼­ ºñÀεΠ¼¼Ã´¾× ´ë½Å Ÿ¾×À» ÀÌ¿ëÇÑ COVID-19 ´ëü Áø´Ü¹ýÀÎ SalivaDirect¿¡ »ç¿ëµÇ¾ú½À´Ï´Ù.

¿¬±¸ÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ º¸°í¼­´Â 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© 2025-2032³âÀÇ ¿¹Ãø ±â°£ Áß ÇÁ·ÎÅ×À̳ªÁ¦ K ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ºÐ¼®ÇÏ¿© ¼¼°è ÇÁ·ÎÅ×À̳ªÁ¦ K ½ÃÀå¿¡ ´ëÇØ »ó¼¼ÇÏ°Ô ¿¬±¸ÇÑ º¸°í¼­ÀÔ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ âÃâ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ÇÁ·ÎÅ×À̳ªÁ¦ K ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ °³¿äÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°èÀÇ Proteinase K ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ÇÁ·ÎÅ×À̳ªÁ¦ K ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • ¸®Æ÷Æ® ¼³¸í
    • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • °³¿ä
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÃÖ±Ù Á¦Ç° ¸±¸®½º
  • ¿ªÇÐ
  • ÇÕº´, Àμö ¹× Çù¾÷
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÁÖ¿ä ¹ßÀü
  • PEST ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ÇÁ·ÎÅ×À̳ª¾ÆÁ¦ K ½ÃÀå, Çüź°, 2020-2032³â

  • µ¿°á°ÇÁ¶ ºÐ¸»
  • ¾×ü

Á¦5Àå ¼¼°èÀÇ ÇÁ·ÎÅ×À̳ª¾ÆÁ¦ K ½ÃÀå, ¿ëµµº°, 2020-2032³â

  • DNA¿Í RNA Á¤Á¦
  • In Situ ÇÏÀ̺긮´ÙÀÌÁ¦À̼Ç
  • ¹ÌÅäÄܵ帮¾Æ ºÐ¸®
  • È¿¼Ò Á¦°Å

Á¦6Àå ¼¼°èÀÇ ÇÁ·ÎÅ×À̳ª¾ÆÁ¦ K ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

  • °è¾à Á¶»ç±â°ü
  • Çмú±â°ü
  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Áø´Ü ¿¬±¸¼Ò

Á¦7Àå ¼¼°èÀÇ ÇÁ·ÎÅ×À̳ª¾ÆÁ¦ K ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • ASEAN
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
      • GCC
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹

Á¦8Àå °æÀï ±¸µµ

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd.
  • New England Biolabs
  • Worthington Biochemical Corporation
  • Norgen Biotek Corp.
  • BIORON GmbH
  • Sisco Research Laboratories Pvt. Ltd
  • Bioline(Meridian Biosciences Inc.)
  • Promega Corporation

Á¦9Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
KSA 25.07.18

Proteinase K Market is estimated to be valued at USD 31.5 Mn in 2025 and is expected to reach USD 48.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 31.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.20% 2032 Value Projection: USD 48.0 Mn

Proteinase K (also known as protease K or endopeptidase K) is a broad-spectrum serine protease widely used in molecular biology. Proteinase K can digest native keratin (hair), hence, the name "Proteinase K". It is commonly used because of its broad specificity, which makes it useful to clean nucleic acid complexes and to lyse cells. It has been used for the isolation of mRNA, and high-molecular-weight DNA and to inactivate other enzymatic activities. The enzyme was discovered in 1974 in extracts of the fungus Engyodontium album (formerly Tritirachium album). Proteinase K is commonly used in molecular biology to digest proteins and remove contamination from preparations of nucleic acid. The addition of proteinase K to nucleic acid preparations rapidly inactivates nucleases that might otherwise degrade the DNA or RNA during purification, hence ideal for these applications. Proteinase K is a cation. It is highly suited to this application since the enzyme is active in the presence of chemicals that denature proteins, such as sodium dodecyl sulphate and urea, chelating agents such as EDTA, sulfhydryl reagents, as well as trypsin or chymotrypsin inhibitors. Proteinase K is used for the destruction of proteins in cell lysates (tissue, cell culture cells) and the release of nucleic acids.

Market Dynamics

In order to accelerate and broaden the development program and to further diversify the company's portfolio, the key market players are focusing on the adoption of growth strategies such as applications of the proteinase K enzyme in novel diagnostic kits which is attributed to the growth of the global Proteinase K market. For instance, according to an article published in the Journal Med, on December 25, 2020, Proteinase K has the potential to work as an affordable, fast, and easy alternative to nucleic acid extraction with only a minor loss of sensitivity. Hence, it was used in SalivaDirect, an alternative diagnostic procedure for COVID-19 that uses saliva instead of nasopharyngeal swabs.

Key features of the study

  • This report provides an in-depth analysis of the global Proteinase K market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Proteinase K market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., F. Hoffmann-La Roche Ltd, New England Biolabs. Worthington Biochemical Corporation, Norgen Biotek Corp., Bioron GmbH, Sisco Research Laboratories Pvt. Ltd., Bioline (Meridian Biosciences Inc.), Promega Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global Proteinase K Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global proteinase K market

Market Segmentation

  • Global Proteinase K Market, By Form
    • Lyophilized Powder Form
    • Liquid Form
  • Global Proteinase K Market, By Application
    • Purificaion of DNA & RNA
    • In situ Hybridization
    • Mitochondria Isolation
    • Enzyme Removal
  • Global Proteinase K Market, By End User
    • Contract Research Organization
    • Academic Institutes
    • Biotechnology Companies
    • Diagnosis Laboratories
  • Global Proteinase K Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Qiagen N.V.
    • F. Hoffmann-La Roche Ltd.
    • New England Biolabs
    • Worthington Biochemical Corporation
    • Norgen Biotek Corp.
    • BIORON GmbH
    • Sisco Research Laboratories Pvt. Ltd.
    • Bioline (Meridian Biosciences Inc.)
    • Promega Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Form
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Proteinase K Market , By Form, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Lyophilized Powder Form
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Liquid Form
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

5. Global Proteinase K Market , By Application, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Purification of DNA & RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • In situ Hybridization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Mitochondria Isolation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Enzyme Removal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

6. Global Proteinase K Market , By End User , 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Contract Research Organization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Diagnostics Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

7. Global Proteinase K Market , By Region, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End user , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End user , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End user , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End user , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End user , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End user , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020- 2032, (US$ Million)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Qiagen N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann- La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • New England Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Worthington Biochemical Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Norgen Biotek Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BIORON GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sisco Research Laboratories Pvt. Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bioline (Meridian Biosciences Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Promega Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦